Abstract

BackgroundDeregulated expression of oncogenes such as MYC and PAX3-FKHR often occurs in rhabdomyosarcomas. MYC can enhance cell proliferation and apoptosis under specific conditions, whereas PAX3-FKHR has only been described as anti-apoptotic.ResultsIn order to evaluate how MYC and PAX3-FKHR oncogenes influenced p53-mediated apoptosis, rhabdomyosarcoma cells were developed to independently express MYC and PAX3-FKHR cDNAs. Exogenous wild-type p53 expression in MYC transfected cells resulted in apoptosis, whereas there was only a slight effect in those transfected with PAX3-FKHR. Both oncoproteins induced BAX, but BAX induction alone without expression of wild-type p53 was insufficient to induce apoptosis. Data generated from genetically modified MEFs suggested that expression of all three proteins; MYC, BAX and p53, was required for maximal cell death to occur.ConclusionWe conclude that cooperation between p53 and oncoproteins to induce apoptosis is dependent upon the specific oncoprotein expressed and that oncogene-mediated induction of BAX is necessary but insufficient to enhance p53-mediated apoptosis. These data demonstrate a novel relationship between MYC and p53-dependent apoptosis, independent of the ability of MYC to induce p53 that may be important in transformed cells other than rhabdomyosarcoma.

Highlights

  • Deregulated expression of oncogenes such as MYC and PAX3-FKHR often occurs in rhabdomyosarcomas

  • The goal of the present study was to evaluate how p53mediated apoptosis is influenced by the expression of two different oncogenes, c-MYC and PAX3-FKHR

  • We demonstrate that apoptosis can be enhanced in cells that express c-MYC together with wild-type p53 and BAX, but that no similar cooperation exists between PAX3-FKHR and p53 or BAX

Read more

Summary

Introduction

Deregulated expression of oncogenes such as MYC and PAX3-FKHR often occurs in rhabdomyosarcomas. MYC can enhance cell proliferation and apoptosis under specific conditions, whereas PAX3-FKHR has only been described as anti-apoptotic. Alveolar rhabdomyosarcomas contain t(2;13) or t(1;13) translocations that generate fusion genes encoding either PAX3 or PAX7 and forkhead (FKHR or FOXO1a) transcription factors [1,2]. The resulting fusion proteins are much stronger transcriptional activators than either PAX3 or PAX7 alone [3]; such increased activity is thought to contribute to the aggressive nature of alveolar rhabdomyosarcoma tumors [4]. PAX3-FKHR expression enhances the proliferation rate and invasiveness of rhabdomyosarcoma tumors [5], and enhances expression of the anti-apoptotic protein BCL-XL [6]. Tumors with PAX3-FKHR often express other deregulated oncogenes [7,8], and Pax3FKHR knock-in mice do not develop tumors [9] suggesting that the oncogenic potential of this fusion protein is weak

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call